BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15017648)

  • 1. Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.
    Karakolios A; Kasapis C; Kallinikidis T; Kalpidis P; Grigoriadis N
    Clin Gastroenterol Hepatol; 2003 Nov; 1(6):480-3. PubMed ID: 15017648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma.
    Dourakis SP; Sinani C; Deutsch M; Dimitriadou E; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):311-4. PubMed ID: 9096437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cholestasis associated with prostate carcinoma.
    Koruk M; Büyükberber M; Savaş C; Kadayifçi A
    Turk J Gastroenterol; 2004 Mar; 15(1):53-5. PubMed ID: 15264123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stauffer's syndrome variant associated with renal cell carcinoma.
    Giannakos G; Papanicolaou X; Trafalis D; Michaelidis I; Margaritis G; Christofilakis C
    Int J Urol; 2005 Aug; 12(8):757-9. PubMed ID: 16174051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stauffer's syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report.
    Tomadoni A; García C; Márquez M; Ayala JC; Prado F
    Arch Esp Urol; 2010 Mar; 63(2):154-6. PubMed ID: 20378939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stauffer's syndrome variant with cholestatic jaundice: a case report.
    Morla D; Alazemi S; Lichtstein D
    J Gen Intern Med; 2006 Jul; 21(7):C11-3. PubMed ID: 16808761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.
    Okano A; Ohana M; Kusumi F
    Clin J Gastroenterol; 2014 Jun; 7(3):278-82. PubMed ID: 26183750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Presenting with Pruritus and Cholestasis.
    Kim YH; Park JM; Kang CD; Seo SO; Lee K; Song G
    Korean J Gastroenterol; 2021 Jul; 78(1):59-64. PubMed ID: 34312359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.
    Kang MK; Park JG; Lee HJ
    Med Princ Pract; 2018; 27(2):197-200. PubMed ID: 29320775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer.
    Kuramoto T; Senzaki H; Koike H; Yamagiwa K; Tamura S; Fujimoto T; Inagaki T
    Case Rep Urol; 2013; 2013():303727. PubMed ID: 24191227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of endoscopic retrograde cholangiopancreatography on the serum IL-18 and erythrocytes antioxidative capacity in biliary obstructive jaundice.
    El-Sayed IH; El kady IM; Badra GA
    Clin Chim Acta; 2003 Oct; 336(1-2):123-8. PubMed ID: 14500044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphoma: a cause of paraneoplastic cholestasis.
    Alirhayim Z; Dyal H; Alarhayem A; Donthireddy V
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23704453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent cholestatic jaundice and nonmetastatic prostatic carcinoma.
    Reddy AN; Grosberg SJ; Wapnick S
    Arch Intern Med; 1977 Nov; 137(11):1616-8. PubMed ID: 921451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma.
    Kato D; Okwara C; Moreland C; Parker A
    J Investig Med High Impact Case Rep; 2014; 2(2):2324709614539927. PubMed ID: 26425613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic examination of duodenal fluid in the differential diagnosis of infantile cholestatic jaundice].
    Huang ZH; Dong YS
    Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):54-6. PubMed ID: 14990109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic jaundice and prostate cancer.
    Vieira AC; Alvarenga MJ; Santos JC; Silva AM
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28433972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-obstructive jaundice as a paraneoplastic syndrome of prostate carcinoma.
    Martín Enguix D; Alarcón Blanco PA; Lacorzana J
    Med Clin (Barc); 2022 Mar; 158(6):294-295. PubMed ID: 34362577
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
    Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
    Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteria.
    Fontes-Sousa M; Magalhães H; da Silva FC; Maurício MJ
    Urol Oncol; 2018 Jul; 36(7):321-326. PubMed ID: 29657090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.